tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

ENTA Stock Latest News

Enanta price target lowered to $20 from $30 at Evercore ISI
The FlyEnanta price target lowered to $20 from $30 at Evercore ISI
11d ago
ENTA
Enanta Pharmaceuticals Reports Promising Results for Pediatric RSV Drug
PremiumCompany Announcements
Enanta Pharmaceuticals Reports Promising Results for Pediatric RSV Drug
13d ago
8K
ENTA
Enanta announces ‘positive’ results from Phase 2 study of zelicapavir
PremiumThe Fly
Enanta announces ‘positive’ results from Phase 2 study of zelicapavir
13d ago
ENTA
Enanta Pharmaceuticals’ Reduced Reporting: Potential Impact on Investor Appeal and Stock Volatility
PremiumCompany Announcements
Enanta Pharmaceuticals’ Reduced Reporting: Potential Impact on Investor Appeal and Stock Volatility
25d ago
ENTA
Enanta price target lowered to $14 from $16 at Oppenheimer
PremiumThe Fly
Enanta price target lowered to $14 from $16 at Oppenheimer
25d ago
ENTA
Enanta price target lowered to $20 from $26 at Baird
PremiumThe FlyEnanta price target lowered to $20 from $26 at Baird
26d ago
ENTA
Enanta price target lowered to $21 from $22 at JMP Securities
Premium
The Fly
Enanta price target lowered to $21 from $22 at JMP Securities
26d ago
ENTA
Enanta Pharmaceuticals Reports Q4 2024 Financials
Premium
Company Announcements
Enanta Pharmaceuticals Reports Q4 2024 Financials
27d ago
ENTA
Closing Bell Movers: Semtech rises, Zoom falls after earnings
PremiumThe Fly
Closing Bell Movers: Semtech rises, Zoom falls after earnings
27d ago
ZM
KSS
Enanta reports Q4 EPS ($1.36), consensus (92c)
PremiumThe Fly
Enanta reports Q4 EPS ($1.36), consensus (92c)
27d ago
ENTA
Enanta Pharmaceuticals (ENTA) Q4 Earnings Cheat Sheet
PremiumPre-Earnings
Enanta Pharmaceuticals (ENTA) Q4 Earnings Cheat Sheet
29d ago
ENTA
Enanta’s EDP-323 meets Phase 2a endpoints in respiratory syncytial virus
PremiumThe Fly
Enanta’s EDP-323 meets Phase 2a endpoints in respiratory syncytial virus
3M ago
ENTA
Enanta Pharmaceuticals reports Q3 EPS ($1.07), consensus ($1.45)
PremiumThe FlyEnanta Pharmaceuticals reports Q3 EPS ($1.07), consensus ($1.45)
5M ago
ENTA
Is ENTA a Buy, Before Earnings?
Premium
Pre-Earnings
Is ENTA a Buy, Before Earnings?
5M ago
ENTA
Enanta price target lowered to $27 from $28 at H.C. Wainwright
Premium
The Fly
Enanta price target lowered to $27 from $28 at H.C. Wainwright
8M ago
ENTA
Enanta price target lowered to $22 from $23 at JMP Securities
PremiumThe Fly
Enanta price target lowered to $22 from $23 at JMP Securities
8M ago
ENTA
Enanta reports Q2 EPS ($1.47), consensus ($1.33)
PremiumThe Fly
Enanta reports Q2 EPS ($1.47), consensus ($1.33)
8M ago
ENTA
ENTA Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
ENTA Upcoming Earnings Report: What to Expect?
8M ago
ENTA
Enanta appoints Matthew Kowalsky as chief legal officer
PremiumThe Fly
Enanta appoints Matthew Kowalsky as chief legal officer
8M ago
ENTA
Enanta Pharmaceuticals Shareholders Affirm Management Direction
PremiumCompany AnnouncementsEnanta Pharmaceuticals Shareholders Affirm Management Direction
9M ago
8K
ENTA
Enanta price target lowered to $17 from $21 at Oppenheimer
Premium
The Fly
Enanta price target lowered to $17 from $21 at Oppenheimer
11M ago
ENTA
Enanta price target lowered to $26 from $40 at Baird
Premium
The Fly
Enanta price target lowered to $26 from $40 at Baird
11M ago
ENTA

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >